Peter Rahmer
CIK: 0001959229
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Relay Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Oct 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct753 shares at avg. $18.62$14K - Aug 26, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct4.5K shares at avg. $20.03$90K - Jul 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct748 shares at avg. $18.61$14K - Jun 30, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct50K shares at avg. $19.09$955K - Jun 30, 2026RLAY
Relay Therapeutics, Inc.
Award(A)Direct3.1K shares at avg. $6.95$21K - Apr 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct753 shares at avg. $14.79$11K - Jan 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct1.4K shares at avg. $8.45$11K - Jan 27, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct11.7K shares at avg. $7.62$89K - Jan 13, 2026RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
475K shares- - Dec 31, 2025RLAY
Relay Therapeutics, Inc.
Award(A)Direct994 shares at avg. $2.99$3K - Oct 29, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct21.4K shares at avg. $7.50$160K - Oct 28, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct19.1K shares at avg. $7.29$139K - Jul 29, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct15.7K shares at avg. $3.68$58K - Jul 28, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct1.4K shares at avg. $3.74$5K - Jun 30, 2025RLAY
Relay Therapeutics, Inc.
Award(A)Direct5K shares at avg. $2.94$15K - Apr 30, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct10.7K shares at avg. $3.00$32K - Apr 28, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct1.4K shares at avg. $3.17$4K - Mar 27, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct247 shares at avg. $2.84$701.48 - Jan 30, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct17.3K shares at avg. $4.42$76K - Jan 29, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct26.5K shares at avg. $4.55$121K - Jan 28, 2025RLAY
Relay Therapeutics, Inc.
Award(A)Direct139.1K shares- - Jan 28, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct1.7K shares at avg. $4.63$8K - Jan 10, 2025RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
275K shares- - Jan 6, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct16.6K shares at avg. $4.45$74K - Jan 3, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct32.2K shares at avg. $4.30$138K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 753 | $18.62 | $14,021 | Direct |
| Aug 26, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 4,508 | $20.03 | $90,295 | Direct |
| Jul 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 748 | $18.61 | $13,920 | Direct |
| Jun 30, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 50,000 | $19.09 | $954,500 | Direct |
| Jun 30, 2026 | RLAY Relay Therapeutics, Inc. | Award(A) | 3,056 | $6.95 | $21,239 | Direct |
| Apr 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 753 | $14.79 | $11,137 | Direct |
| Jan 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 1,354 | $8.45 | $11,441 | Direct |
| Jan 27, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 11,684 | $7.62 | $89,032 | Direct |
| Jan 13, 2026 | RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 475,000 | - | - | Direct |
| Dec 31, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) | 994 | $2.99 | $2,972 | Direct |
| Oct 29, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 21,394 | $7.50 | $160,455 | Direct |
| Oct 28, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 19,135 | $7.29 | $139,494 | Direct |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 15,724 | $3.68 | $57,864 | Direct |
| Jul 28, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 1,359 | $3.74 | $5,083 | Direct |
| Jun 30, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) | 5,000 | $2.94 | $14,700 | Direct |
| Apr 30, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 10,739 | $3.00 | $32,217 | Direct |
| Apr 28, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 1,364 | $3.17 | $4,324 | Direct |
| Mar 27, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 247 | $2.84 | $701 | Direct |
| Jan 30, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 17,250 | $4.42 | $76,245 | Direct |
| Jan 29, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 26,541 | $4.55 | $120,762 | Direct |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) | 139,141 | - | $0 | Direct |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 1,673 | $4.63 | $7,746 | Direct |
| Jan 10, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 275,000 | - | - | Direct |
| Jan 6, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 16,576 | $4.45 | $73,763 | Direct |
| Jan 3, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 32,177 | $4.30 | $138,361 | Direct |
1-25 of 29 transactions
About Rahmer Peter
Rahmer Peter (SEC CIK 0001959229) files insider reports with the SEC as Officer of Relay Therapeutics, Inc. (RLAY).
Signal8 holds 18 ownership filings by Rahmer Peter, all Form 4s, filed between Oct 1, 2024 and Oct 30, 2026. Those filings report 29 transactions, from Sep 27, 2024 to Oct 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rahmer Peter's filings is in CAMBRIDGE, MA.
Recent filings by Rahmer Peter
- Oct 28, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Aug 26, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Jul 28, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Jun 30, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Jun 30, 2026: Grant or award of RLAY shares (Form 4, code A).
Other insiders filing for Relay Therapeutics, Inc. (RLAY)
- Bergstrom Donald A, President, R&D
- Catinazzo Thomas, Chief Financial Officer
- Patel Sanjiv, President and CEO
- SVF Pauling (Cayman) Ltd, 10% Owner
- Mazumdar Claire, Director
- Dable Habib J, Director